$PG · The Procter & Gamble Company

The Procter & Gamble Company filed a Form 4 disclosing transactions by Moses Victor Javier Aguilar, the company’s Chief Research, Development & Innovation Officer. On October 30, 2026, he exercised stock options to acquire 18,812 shares of common stock at an exercise price of $78.52 per share. The options were originally granted on February 26, 2021, with an expiration date of February 28, 2028.

On the same day, Aguilar sold all 18,812 shares acquired through the option exercise at a weighted average price of $164.4342 per share. The sale prices ranged from $164.39 to $164.515 per share. Following these transactions, his direct holdings in P&G common stock totaled 55,243.0935 shares. The filing also reported indirect holdings of 7,546.1382 shares through a retirement plan trustee and 428.6033 shares through an international stock ownership plan trustee in Mexico. After the reported exercise, no stock options remained beneficially owned by the reporting person.